Search results
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 3 hours agoIf approved, Novavax would finally be able to market its only commercially available product during the fall vaccine season, alongside rivals Pfizer...
Pfizer (NYSE:PFE) Trading 0.3% Higher
ETF DAILY NEWS· 15 hours agoPfizer Inc. (NYSE:PFE – Get Free Report) traded up 0.3% during mid-day trading on Tuesday . The company traded as high as $29.73 and last traded at $29.41. 9,834,266 shares ...
Why Things Could Get Worse for Pfizer Stock Before They Get Better | The Motley Fool
The Motley Fool· 1 day agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (PFE 0.20%) stock was a hot buy...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 6 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 8 hours agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
How To Earn $500 A Month From Pfizer Stock
Benzinga via AOL· 6 days agoShares of Pfizer Inc. (NYSE:PFE) closed higher during Thursday's session, with the company's stock adding around 10% over the past month. Pfizer recently...
Is Pfizer Inc. (NYSE:PFE) the Best Gene Therapy Stock to Buy Now?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Relay in clinical trial collaboration with Pfizer for breast cancer combo treatment
Seeking Alpha· 1 day agoRelay Therapeutics collaborates with Pfizer to investigate combination therapy for breast cancer using RLY-2608 and atirmociclib. Read more here.
Is Pfizer the Best Dividend Stock for You?
Motley Fool via Yahoo Finance· 6 days agoThe pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (NYSE: PFE) benefitted a few years ago has trickled down to a small stream....
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 3 hours agoPfizer and Moderna are also planning to prepare JN.1-focused boosters. Novavax stock has been on a...